Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 127

1.

Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study.

Baratti D, Kusamura S, Milione M, Pietrantonio F, Caporale M, Guaglio M, Deraco M.

Ann Surg Oncol. 2016 Dec;23(13):4222-4230. Epub 2016 Jun 28.

PMID:
27352203
2.

Toward the molecular dissection of peritoneal pseudomyxoma.

Pietrantonio F, Perrone F, Mennitto A, Gleeson EM, Milione M, Tamborini E, Busico A, Settanni G, Berenato R, Caporale M, Morano F, Bossi I, Pellegrinelli A, Di Bartolomeo M, de Braud F, Baratti D, Bowne WB, Kusamura S, Deraco M.

Ann Oncol. 2016 Nov;27(11):2097-2103. Epub 2016 Aug 8.

PMID:
27502722
3.

A multidisciplinary telehealth program in patients with combined chronic obstructive pulmonary disease and chronic heart failure: study protocol for a randomized controlled trial.

Bernocchi P, Scalvini S, Galli T, Paneroni M, Baratti D, Turla O, La Rovere MT, Volterrani M, Vitacca M.

Trials. 2016 Sep 22;17(1):462.

4.

Home-Based Telemedicine in Patients with Chronic Neck Pain.

Gialanella B, Ettori T, Faustini S, Baratti D, Bernocchi P, Comini L, Scalvini S.

Am J Phys Med Rehabil. 2017 May;96(5):327-332. doi: 10.1097/PHM.0000000000000610.

PMID:
27584139
5.

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases.

Baratti D, Kusamura S, Iusco D, Gimondi S, Pietrantonio F, Milione M, Guaglio M, Bonomi S, Grassi A, Virzì S, Leo E, Deraco M.

Ann Surg Oncol. 2017 Jan;24(1):167-175. doi: 10.1245/s10434-016-5488-5. Epub 2016 Aug 12.

PMID:
27519353
6.

GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study.

Pietrantonio F, Berenato R, Maggi C, Caporale M, Milione M, Perrone F, Tamborini E, Baratti D, Kusamura S, Mariani L, Niger M, Mennitto A, Gloghini A, Bossi I, Settanni G, Busico A, Bagnoli PF, Di Bartolomeo M, Deraco M, de Braud F.

J Transl Med. 2016 May 6;14(1):125. doi: 10.1186/s12967-016-0877-x.

7.

Home-based telesurveillance and rehabilitation after stroke: a real-life study.

Bernocchi P, Vanoglio F, Baratti D, Morini R, Rocchi S, Luisa A, Scalvini S.

Top Stroke Rehabil. 2016 Apr;23(2):106-15. doi: 10.1080/10749357.2015.1120453. Epub 2016 Jan 9.

PMID:
27078116
8.
9.

Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic review.

Baratti D, Kusamura S, Pietrantonio F, Guaglio M, Niger M, Deraco M.

Crit Rev Oncol Hematol. 2016 Apr;100:209-22. doi: 10.1016/j.critrevonc.2016.01.017. Epub 2016 Jan 22. Review.

PMID:
26867984
10.

Treatment principles for peritoneal surface malignancies.

Deraco M, Kusamura S, Corbellini C, Guaglio M, Paviglianiti C, Baratti D.

Minerva Chir. 2016 Apr;71(2):124-45. Epub 2016 Feb 5.

PMID:
26847729
11.

The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Kusamura S, Torres Mesa PA, Cabras A, Baratti D, Deraco M.

Ann Surg Oncol. 2016 May;23(5):1468-73. doi: 10.1245/s10434-015-4962-9. Epub 2015 Nov 16.

PMID:
26572754
12.

The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

Kusamura S, Baratti D, Hutanu I, Gavazzi C, Morelli D, Iusco DR, Grassi A, Bonomi S, Virzì S, Haeusler E, Deraco M.

Eur J Surg Oncol. 2015 Aug;41(8):1097-105. doi: 10.1016/j.ejso.2015.04.005. Epub 2015 May 16.

PMID:
26026742
13.

Immunohistochemical Evaluation of Minichromosome Maintenance Protein 7 (MCM7), Topoisomerase IIα, and Ki-67 in Diffuse Malignant Peritoneal Mesothelioma Patients Using Tissue Microarray.

Deraco M, Cabras A, Baratti D, Kusamura S.

Ann Surg Oncol. 2015 Dec;22(13):4344-51. doi: 10.1245/s10434-015-4498-z. Epub 2015 Mar 17.

PMID:
25777091
14.

Epidural analgesia for cytoreductive surgery with peritonectomy and heated intraperitoneal chemotherapy.

Piccioni F, Casiraghi C, Fumagalli L, Kusamura S, Baratti D, Deraco M, Arienti F, Langer M.

Int J Surg. 2015 Apr;16(Pt A):99-106. doi: 10.1016/j.ijsu.2015.02.025. Epub 2015 Mar 11.

15.

Peritoneal metastases: challenges for the surgeon.

Baratti D, Kusamura S, Guaglio M, Deraco M.

Minerva Chir. 2015 Jun;70(3):195-215. Epub 2015 Mar 10. Review.

PMID:
25752673
16.

In reply.

Baratti D, Kusamura S, Maggi C, de Braud F, Deraco M, Di Bartolomeo M, Pietrantonio F.

Oncologist. 2015 Mar;20(3):e5. doi: 10.1634/theoncologist.2014-423. No abstract available.

17.

The role of hyperthermic intraperitoneal chemotherapy (HIPEC) and isolated perfusion (ILP) interventions in sarcoma.

Colombo C, Baratti D, Kusamura S, Deraco M, Gronchi A.

J Surg Oncol. 2015 Apr;111(5):570-9. doi: 10.1002/jso.23808. Epub 2014 Oct 28. Review.

PMID:
25351775
18.

Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei.

Kusamura S, Moran BJ, Sugarbaker PH, Levine EA, Elias D, Baratti D, Morris DL, Sardi A, Glehen O, Deraco M; Peritoneal Surface Oncology Group International (PSOGI)..

Br J Surg. 2014 Dec;101(13):1758-65. doi: 10.1002/bjs.9674. Epub 2014 Oct 20.

PMID:
25329419
19.

The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery.

Prada-Villaverde A, Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, Baumgartner JM, Berri R, Bretcha-Boix P, Deraco M, Flores-Ayala G, Glehen O, Gomez-Portilla A, González-Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spiliotis J, Torres-Melero J, Turaga K, Trout R.

J Surg Oncol. 2014 Dec;110(7):779-85. doi: 10.1002/jso.23728. Epub 2014 Aug 2.

PMID:
25088304
20.

FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma.

Pietrantonio F, Maggi C, Fanetti G, Iacovelli R, Di Bartolomeo M, Ricchini F, Deraco M, Perrone F, Baratti D, Kusamura S, Tamborini E, Castano A, Consonni PV, Bossi I, Gavazzi C, Milione M, Pelosi G, de Braud F.

Oncologist. 2014 Aug;19(8):845-50. doi: 10.1634/theoncologist.2014-0106. Epub 2014 Jun 20.

Supplemental Content

Loading ...
Support Center